1 |
Valencia K, Echepare M, Teijeira Á, Pasquier A, Bértolo C, Sainz C, Tamayo I, Picabea B, Bosco G, Thomas R, Agorreta J, López-Picazo JM, Frigola J, Amat R, Calvo A, Felip E, Melero I, Montuenga LM. DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity. J Exp Med 2022;219:e20220726. [PMID: 36169652 DOI: 10.1084/jem.20220726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
2 |
Tang C, Liu J, Yang C, Ma J, Chen X, Liu D, Zhou Y, Zhou W, Lin Y, Yuan X. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations. Biomolecules 2022;12:1636. [DOI: 10.3390/biom12111636] [Reference Citation Analysis]
|
3 |
Tang Q, Chen Y, Li X, Long S, Shi Y, Yu Y, Wu W, Han L, Wang S. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol 2022;13:964442. [DOI: 10.3389/fimmu.2022.964442] [Reference Citation Analysis]
|
4 |
Tabashiri R, Sharifi S, Pakdel A, Bakhtiarizadeh MR, Pakdel MH, Tahmasebi A, Hercus C. Genome-wide post-transcriptional regulation of bovine mammary gland response to Streptococcus uberis. J Appl Genet 2022. [PMID: 36066834 DOI: 10.1007/s13353-022-00722-y] [Reference Citation Analysis]
|
5 |
Huang Z, Yu C, Yu L, Shu H, Zhu X. The Roles of FHL3 in Cancer. Front Oncol 2022;12:887828. [PMID: 35686099 DOI: 10.3389/fonc.2022.887828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|